Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity

BACKGROUND & AIMS: The sodium taurocholate co-transporting polypeptide (NTCP) is the main target of most hepatitis B virus (HBV) specific entry inhibitors. Unfortunately, these agents also block NTCP transport of bile acids into hepatocytes, and thus have the potential to cause adverse effects....

Descripción completa

Detalles Bibliográficos
Autores principales: Shimura, Satomi, Watashi, Koichi, Fukano, Kento, Peel, Michael, Sluder, Ann, Kawai, Fumihiro, Iwamoto, Masashi, Tsukuda, Senko, Takeuchi, Junko S., Miyake, Takeshi, Sugiyama, Masaya, Ogasawara, Yuki, Park, Sam-Yong, Tanaka, Yasuhito, Kusuhara, Hiroyuki, Mizokami, Masashi, Sureau, Camille, Wakita, Takaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172969/
https://www.ncbi.nlm.nih.gov/pubmed/27890789
http://dx.doi.org/10.1016/j.jhep.2016.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172969/
https://www.ncbi.nlm.nih.gov/pubmed/27890789
http://dx.doi.org/10.1016/j.jhep.2016.11.009

Ejemplares similares